Polypill in Acute Coronary Syndrome

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

Also called NCT05514938

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 140 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05514938
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05514938. Randomized; no masking; primary purpose treatment. Start 2022-11-30 (actual); primary completion 2025-05-30 (actual). Results posted on 2026-05-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Polypill in Acute Coronary Syndrome
Acronym
POLY-ACS
Condition
Acute Coronary Syndrome
Condition
Lipid Disorder
Intervention (Drug)
Polypill
Intervention (Drug)
Usual Care (individual medications prescribed by primary cardiologist)
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct05514938
Content hash
05306b953d284c0a0594be47e67cb778469e52942578494d8415a61f9a291776